Qifeng Chen

1.9k total citations
83 papers, 1.4k citations indexed

About

Qifeng Chen is a scholar working on Hepatology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Qifeng Chen has authored 83 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Hepatology, 23 papers in Pulmonary and Respiratory Medicine and 22 papers in Molecular Biology. Recurrent topics in Qifeng Chen's work include Hepatocellular Carcinoma Treatment and Prognosis (24 papers), Liver Disease Diagnosis and Treatment (9 papers) and Ferroptosis and cancer prognosis (8 papers). Qifeng Chen is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (24 papers), Liver Disease Diagnosis and Treatment (9 papers) and Ferroptosis and cancer prognosis (8 papers). Qifeng Chen collaborates with scholars based in China, United States and Singapore. Qifeng Chen's co-authors include Wang Li, Lujun Shen, Peihong Wu, Tao Huang, Ming Zhao, Ning Lyu, Zilin Huang, Haijing Deng, Boyang Chang and Rui Wang and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Qifeng Chen

72 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qifeng Chen China 22 523 346 331 323 307 83 1.4k
Xinsen Xu China 20 427 0.8× 469 1.4× 300 0.9× 305 0.9× 256 0.8× 46 1.3k
Yinying Lu China 24 620 1.2× 432 1.2× 298 0.9× 302 0.9× 656 2.1× 99 1.8k
Matteo Canale Italy 17 360 0.7× 443 1.3× 403 1.2× 394 1.2× 120 0.4× 43 1.1k
Ik Joo Chung South Korea 19 416 0.8× 352 1.0× 232 0.7× 278 0.9× 401 1.3× 57 1.4k
Joji Tani Japan 21 712 1.4× 434 1.3× 457 1.4× 249 0.8× 418 1.4× 125 1.7k
Yan Zhu China 21 518 1.0× 399 1.2× 347 1.0× 243 0.8× 97 0.3× 69 1.3k
Yusuke Arakawa Japan 24 350 0.7× 306 0.9× 149 0.5× 157 0.5× 535 1.7× 95 1.5k
Masaki Mizumoto Japan 15 517 1.0× 510 1.5× 320 1.0× 193 0.6× 395 1.3× 24 1.5k
Shu Cao United States 23 478 0.9× 502 1.5× 237 0.7× 209 0.6× 92 0.3× 114 1.5k
Petra Ruemmele Germany 25 430 0.8× 564 1.6× 295 0.9× 401 1.2× 246 0.8× 49 1.6k

Countries citing papers authored by Qifeng Chen

Since Specialization
Citations

This map shows the geographic impact of Qifeng Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qifeng Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qifeng Chen more than expected).

Fields of papers citing papers by Qifeng Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qifeng Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qifeng Chen. The network helps show where Qifeng Chen may publish in the future.

Co-authorship network of co-authors of Qifeng Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Qifeng Chen. A scholar is included among the top collaborators of Qifeng Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qifeng Chen. Qifeng Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Qıang, et al.. (2025). Identification of a novel Songorine derivative as a potent NLRP3 inflammasome inhibitor. Bioorganic & Medicinal Chemistry Letters. 133. 130511–130511.
2.
3.
4.
5.
6.
Liu, Yongxiang, Haijing Deng, Feng Cheng, et al.. (2024). Serum amyloid A promotes glycolysis of neutrophils during PD-1 blockade resistance in hepatocellular carcinoma. Nature Communications. 15(1). 1754–1754. 26 indexed citations
7.
Chen, Qifeng, et al.. (2024). Incidence and influencing factors for respiratory sarcopenia in older adults: The first longitudinal evidence from the CHARLS. Geriatrics and gerontology international. 24(10). 1015–1021.
8.
9.
Chen, Kangkang, et al.. (2023). Prevalence and effect on survival of pre-treatment sarcopenia in patients with hematological malignancies: a meta-analysis. Frontiers in Oncology. 13. 1249353–1249353. 4 indexed citations
10.
Zhu, Zhijian, Jie Xu, Ke Ding, et al.. (2023). Hepatic arterial infusion therapy for advanced hepatocellular carcinoma after systemic treatment failure: Multicenter, real‐world study. Hepatology Research. 54(6). 575–587. 3 indexed citations
11.
Shen, Lujun, Ying Wu, Han Qi, et al.. (2022). Inducible Regulatory T Cell Predicts Efficacy of PD‐1 Blockade Therapy in Melanoma. Advanced Therapeutics. 5(4). 2 indexed citations
12.
Zeng, Rong, et al.. (2021). The effect of epidural analgesia on maternal-neonatal outcomes: a retrospective study. Ginekologia Polska. 7 indexed citations
13.
Zhang, Hao, Qifeng Chen, Na Shang, et al.. (2021). The enhanced mechanisms of Hansschlegelia zhihuaiae S113 degrading bensulfuron-methyl in maize rhizosphere by three organic acids in root exudates. Ecotoxicology and Environmental Safety. 223. 112622–112622. 22 indexed citations
14.
Xiang, Yun, et al.. (2020). A novel esterase LanE from Edaphocola flava HME-24 and the enantioselective degradation mechanism of herbicide lactofen. Ecotoxicology and Environmental Safety. 205. 111141–111141. 10 indexed citations
15.
Li, Wang, et al.. (2020). Bioinformatic analysis and in vitro validation of a five-microRNA signature as a prognostic biomarker of hepatocellular carcinoma. Annals of Translational Medicine. 8(21). 1422–1422. 5 indexed citations
16.
Chen, Qifeng, et al.. (2019). Predictive value of a nomogram for hepatocellular carcinoma with brain metastasis at initial diagnosis: A population-based study. PLoS ONE. 14(1). e0209293–e0209293. 15 indexed citations
17.
Zhang, Tao, Rui Yan, Qifeng Chen, et al.. (2018). Body mass index, waist-to-hip ratio and cognitive function among Chinese elderly: a cross-sectional study. BMJ Open. 8(10). e022055–e022055. 32 indexed citations
18.
Jing, Mingxue, Fei Gao, Qifeng Chen, et al.. (2016). Comparison of Long-Term Mortality of Patients Aged ≤40 Versus >40 Years With Acute Myocardial Infarction. The American Journal of Cardiology. 118(3). 319–325. 6 indexed citations
19.
Carvalho, Leonardo Pinto de, Fei Gao, Qifeng Chen, et al.. (2015). Long-Term Prognosis and Risk Heterogeneity of Heart Failure Complicating Acute Myocardial Infarction. The American Journal of Cardiology. 115(7). 872–878. 19 indexed citations
20.
Chen, Qifeng, et al.. (2010). Clinical value of measuring serum osteoprotegerin in patients with prostate cancer.. 26(12). 1242–1243. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xinsen Xu Breakdown of academic impact, for papers by Yinying Lu Breakdown of academic impact, for papers by Matteo Canale Breakdown of academic impact, for papers by Ik Joo Chung Breakdown of academic impact, for papers by Joji Tani Breakdown of academic impact, for papers by Yan Zhu Breakdown of academic impact, for papers by Yusuke Arakawa Breakdown of academic impact, for papers by Masaki Mizumoto Breakdown of academic impact, for papers by Shu Cao Breakdown of academic impact, for papers by Petra Ruemmele
Rankless by CCL
2026